Organ-preserving multimodality management of squamous cell carcinoma of anal canal

Indian Journal of Gastroenterology

Volumn 24, Issue 5, 2005, Pages 201-204

  Deo, S V ^a   Shukla, N K ^a   Raina, V ^a   Mohanti, B K ^a   Sharan, Rajeev ^a   Kar, Madhabananda ^a   Rath, G K ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; METHOTREXATE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COLOSTOMY; CONTROLLED STUDY; CYSTITIS; DISEASE FREE SURVIVAL; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYDRATION; INGUINAL LYMPH NODE; MALE; MUCOSA INFLAMMATION; ORGAN PRESERVATION; PROCTITIS; RECURRENT CANCER; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; STENOSIS; TREATMENT FAILURE; ULCER; WOUND HEALING IMPAIRMENT; ANAL CANAL; ANUS TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY;

ADULT; AGED; ANAL CANAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COLOSTOMY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; METHOTREXATE; MIDDLE AGED; SALVAGE THERAPY;

EID: 33644807151     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Papillon J, Mayer M, Monthbarbon JA. New approach to the management of epidermoid carcinoma of the anal canal. Cancer 1983;51:1830-7.
2. Cummings B. The place of radiation therapy in the treatment of carcinoma of the anal canal. Cancer Treat Rev 1982;9:125-47.
3. Nigro N, Vaitkevicius VK, Considine B Jr. Combined preoperative radiation and chemotherapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;15:354-6.
4. Flam MS, John MJ, Lovalvo LJ, Mills RJ, Ramalho LD, Prather C, et al . Definitive non surgical therapy of epithelial malignancies of the anal canal: a report of 12 cases. Cancer 1983;51:1378-87.
5. Cummings B, Keane T, Gillian T, Thomas G, Harwood A, Rider W. Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy. Cancer 1984;54:2062-8.
6. Leichman L, Nigro N, Vaitkevicius VK, Considine B, Buroker T, Bradley G, et al . Cancer of the anal canal: model for preoperative adjuvant combined modality treatment. Am J Med 1985;78:211-6.
7. Flam MS, John MJ, Mowry PA, Lovalvo LJ, Ramalho LD, Wade J. Definitive combined modality therapy of carcinoma of the anus: a report of 30 cases including results of salvage therapy in patients with residual disease. Dis Colon Rectum 1987;30:495-502.
8. Meeker WR, Sickie-Santanello BJ, Philpotti G, Kenady D, Bland KI, Hill GH, et al . Combined chemotherapy, radiation and surgery for epithelial cancer of the anal canal. Cancer 1986;57:525-9.
9. Sobin LH, Wittekind CH, Eds. UICC International Union Against Cancer. TNM classification of malignant tumors, 5th ed. New York: Weily-Liss. 1997: p. 70-3.
10. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al . Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organisation for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15:2040-9.
11. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-FU, and mitomycin. Lancet 1996;348:1049-54.
12. Flam M, John.M, Pajak TF, Petrelli N, Myerson R, Doggett S, et al . Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive non surgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996;14:2527-39.
13. Svensson C, Goldmann S, Friberg B, Glimelius B. Induction chemotherapy and radiotherapy in loco-regionally advanced epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1998;41:863-7.
14. Peiffert D, Giovannini M, Ducreux M, Michel P, Francois E, Lemanski C, et al . High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-FU and cisplatin in patients with locally advanced squamous cell anal cancer: final results of a phase II study. Ann Oncol 2001;12:397-404.
15. Amrein PC, Fabian RL. Treatment of recurrent head and neck cancer with cisplatin and 5-FU vs. the same plus bleomycin and methotrexate. Laryngoscope 1992;102:901-6.
16. Corral DA, Sella A, Pettaway CA, Amato RJ, Jones DM, Ellerhorst J. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II studies of methotrexate, cisplatin and bleomycin. J Urol 1998;160:1770-4.
17. DeBesi P, Salvagno L, Endrizzil, Sileni VC, Fosser V, Cartei G, et al . Cisplatin, bleomycin and methotrexate in the treatment of advanced oesophageal cancer. Eur J Cancer Clin Oncol 1984;20:743-7.
18. Roth AD, Berney CR, Rohner S, Allal AS, Morel P, Marti MC, et al . Intraarterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potential. Br J Cancer 2000;83:1637-42.
19. Wilking N, Petrelli N, Herrera L, Mittelman A. Phase II study of combination bleomycin, vincristine and high dose methotrexate (BOM) with lecovorin rescue in advanced squamous cell carcinoma of the anal canal. Cancer Chemother Pharmacol 1985;15:300-2.
20. Deniaud-Alexandre E, Touboul E, Tiret E, Sezeur A, Houry S, Gallot D, et al . Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiation Oncology Biol Phys 2003;56:1259-73.
21. Hung A, Crane C, Delclos M, Ballo M, Ajani J, Lin E, et al . Cisplatin based modality therapy for anal carcinoma. Cancer 2003;97:1195-202.